Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $67.68 USD
Change Today +0.40 / 0.59%
Volume 3.1M
CL On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
Bogota
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

colgate-palmolive co (CL) Key Developments

Colgate-Palmolive Company Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Colgate-Palmolive Company announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $4,070 million against $4,325 million a year ago. Operating profit was $860 million against $634 million a year ago. Income before income taxes was $852 million against $627 million a year ago. Net income attributable to Colgate-Palmolive Company was $542 million or $0.59 per diluted share against $388 million or $0.42 per diluted share a year ago. Net cash provided by operations was $727 million compared to $820 million in the comparable 2014 period, primarily due to lower operating earnings and an increase in tax receivables. Capital expenditures were $122 million against $168 million a year ago. Operating profit, non-GAAP was $960 million against $1,003 million a year ago. Net income attributable to Colgate-Palmolive Company non-GAAP was $609 million or $0.66 per diluted share against $636 million or $0.68 per diluted share a year ago.

Colgate-Palmolive Hit with $13 Million Mesothelioma Verdict in California

Simon Greenstone Panatier Bartlett, PC have won a $13 million jury verdict on behalf of a 73-year-old woman who contracted mesothelioma after using asbestos-containing talcum powder manufactured by Colgate-Palmolive Company. The April 28 verdict was handed down by a jury in Los Angeles Superior Court following only two hours of deliberations. Jurors assigned 95% liability against Colgate-Palmolive based on plaintiff Judith Winkel's claims that the company's talcum powder products caused her to contract mesothelioma, a fatal lung disease. Ms. Winkel was diagnosed with mesothelioma in January 2014 after using Cashmere Bouquet manufactured by Colgate-Palmolive. Most people who are diagnosed with mesothelioma die within two years of diagnosis, says Simon Greenstone name shareholder Chris Panatier, who represented Ms. Winkel and her husband, John. The jury unanimously found in favor of Ms. Winkel and her husband on five counts: consumer expectations, risk-benefit, manufacturing defect, failure to warn and negligence. The jury also found that Colgate-Palmolive acted with malice. Following the verdict, the parties reached a confidential settlement before the trial's punitive damages phase was set to begin.

Colgate-Palmolive Co., Q1 2015 Earnings Call, Apr 30, 2015

Colgate-Palmolive Co., Q1 2015 Earnings Call, Apr 30, 2015

Colgate-Palmolive Announces Board Changes

Colgate-Palmolive Company announced that John P. Bilbrey, President and Chief Executive Officer of The Hershey Company, has been elected to Colgate’s Board of Directors. Mr. Bilbrey, 58, brings considerable operational leadership experience and in-depth knowledge of the fast-moving consumer goods industry to the Colgate Board. Prior to joining The Hershey Company in 2003, Mr. Bilbrey served as Executive Vice President, Sales at Mission Foods and as President and Chief Executive Officer at Danone Waters of North America. He also served in positions of increasing responsibility in the United States and internationally during his 22 years at The Procter & Gamble Company. Separately, the company announced that the Board of Directors had accepted the resignation of Joseph Jimenez, Chief Executive Officer of Novartis, who served on Colgate’s Board of Directors since 2010. The Directors extended to Mr. Jimenez their sincere thanks for all of his contributions.

Colgate-Palmolive Mulls Acquisitions

Colgate-Palmolive Co. (NYSE:CL) is seeking acquisitions in the oral care, pet nutrition, and personal care areas.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CL:US $67.68 USD +0.40

CL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Danone SA €64.51 EUR +0.13
Ecolab Inc $113.95 USD +1.97
General Mills Inc $55.70 USD +0.36
Kimberly-Clark Corp $111.04 USD +1.35
Reckitt Benckiser Group PLC 5,800 GBp -26.00
View Industry Companies
 

Industry Analysis

CL

Industry Average

Valuation CL Industry Range
Price/Earnings 26.7x
Price/Sales 3.6x
Price/Book 133.6x
Price/Cash Flow 26.3x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLGATE-PALMOLIVE CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.